vs
应用材料（AMAT）与TENET HEALTHCARE CORP（THC）财务数据对比。点击上方公司名可切换其他公司
应用材料的季度营收约是TENET HEALTHCARE CORP的1.4倍（$7.9B vs $5.5B），应用材料净利率更高（35.5% vs 11.7%，领先23.8%），应用材料同比增速更快（11.0% vs 9.0%），过去两年应用材料的营收复合增速更高（8.0% vs 1.5%）
应用材料是总部位于美国加利福尼亚州圣克拉拉的企业，为全球第二大半导体设备供应商，主营半导体芯片、消费电子平板显示、太阳能产品制造所需的设备、服务及软件，同时供应柔性电子、封装等领域的涂层生产设备。
Tenet Healthcare Corporation是总部位于美国达拉斯的营利性跨国医疗服务企业，旗下拥有USPI等多个品牌、子公司、合资企业及合作主体，运营65家医院及超过450个医疗设施，还通过旗下Conifer Health Solutions为各类医疗系统及其他客户提供专业医疗支持服务
AMAT vs THC — 直观对比
营收规模更大
AMAT
是对方的1.4倍
$5.5B
营收增速更快
AMAT
高出2.0%
9.0%
净利率更高
AMAT
高出23.8%
11.7%
两年增速更快
AMAT
近两年复合增速
1.5%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $7.9B | $5.5B |
| 净利润 | $2.8B | $644.0M |
| 毛利率 | 49.9% | — |
| 营业利润率 | 26.4% | 15.4% |
| 净利率 | 35.5% | 11.7% |
| 营收同比 | 11.0% | 9.0% |
| 净利润同比 | 31.0% | 12.6% |
| 每股收益（稀释后） | $3.51 | $4.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMATTHC
| Q2 26 | $7.9B | — | ||
| Q1 26 | $7.0B | — | ||
| Q4 25 | $6.8B | $5.5B | ||
| Q3 25 | $7.3B | $5.3B | ||
| Q2 25 | $7.1B | $5.3B | ||
| Q1 25 | $7.2B | $5.2B | ||
| Q4 24 | $7.0B | $5.1B | ||
| Q3 24 | $6.8B | $5.1B |
净利润AMATTHC
| Q2 26 | $2.8B | — | ||
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $644.0M | ||
| Q3 25 | $1.8B | $579.0M | ||
| Q2 25 | $2.1B | $522.0M | ||
| Q1 25 | $1.2B | $622.0M | ||
| Q4 24 | $1.7B | $572.0M | ||
| Q3 24 | $1.7B | $681.0M |
毛利率AMATTHC
| Q2 26 | 49.9% | — | ||
| Q1 26 | 49.0% | — | ||
| Q4 25 | 48.0% | — | ||
| Q3 25 | 48.8% | — | ||
| Q2 25 | 49.1% | — | ||
| Q1 25 | 48.8% | — | ||
| Q4 24 | 47.3% | — | ||
| Q3 24 | 47.3% | — |
营业利润率AMATTHC
| Q2 26 | 26.4% | — | ||
| Q1 26 | 20.4% | — | ||
| Q4 25 | 25.2% | 15.4% | ||
| Q3 25 | 30.6% | 16.8% | ||
| Q2 25 | 30.5% | 15.6% | ||
| Q1 25 | 30.4% | 18.1% | ||
| Q4 24 | 29.0% | 16.2% | ||
| Q3 24 | 28.7% | 21.3% |
净利率AMATTHC
| Q2 26 | 35.5% | — | ||
| Q1 26 | 28.9% | — | ||
| Q4 25 | 27.9% | 11.7% | ||
| Q3 25 | 24.4% | 10.9% | ||
| Q2 25 | 30.1% | 9.9% | ||
| Q1 25 | 16.5% | 11.9% | ||
| Q4 24 | 24.6% | 11.3% | ||
| Q3 24 | 25.2% | 13.3% |
每股收益（稀释后）AMATTHC
| Q2 26 | $3.51 | — | ||
| Q1 26 | $2.54 | — | ||
| Q4 25 | $2.36 | $4.22 | ||
| Q3 25 | $2.22 | $3.86 | ||
| Q2 25 | $2.63 | $3.14 | ||
| Q1 25 | $1.45 | $4.27 | ||
| Q4 24 | $2.09 | $3.79 | ||
| Q3 24 | $2.05 | $4.89 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.2B | $2.9B |
| 总债务越低越好 | $6.5B | $13.1B |
| 股东权益账面价值 | $23.9B | $4.2B |
| 总资产 | $40.3B | $29.7B |
| 负债/权益比越低杠杆越低 | 0.27× | 3.10× |
8季度趋势，按日历期对齐
现金及短期投资AMATTHC
| Q2 26 | $8.2B | — | ||
| Q1 26 | $8.5B | — | ||
| Q4 25 | $8.6B | $2.9B | ||
| Q3 25 | $7.0B | $3.0B | ||
| Q2 25 | $6.7B | $2.6B | ||
| Q1 25 | $8.2B | $3.0B | ||
| Q4 24 | $9.5B | $3.0B | ||
| Q3 24 | $9.1B | $4.1B |
总债务AMATTHC
| Q2 26 | $6.5B | — | ||
| Q1 26 | $6.6B | — | ||
| Q4 25 | — | $13.1B | ||
| Q3 25 | — | $13.1B | ||
| Q2 25 | — | $13.1B | ||
| Q1 25 | — | $13.1B | ||
| Q4 24 | — | $13.1B | ||
| Q3 24 | — | $12.8B |
股东权益AMATTHC
| Q2 26 | $23.9B | — | ||
| Q1 26 | $21.7B | — | ||
| Q4 25 | $20.4B | $4.2B | ||
| Q3 25 | $19.5B | $4.0B | ||
| Q2 25 | $19.0B | $3.7B | ||
| Q1 25 | $18.6B | $4.2B | ||
| Q4 24 | $19.0B | $4.2B | ||
| Q3 24 | $18.8B | $3.8B |
总资产AMATTHC
| Q2 26 | $40.3B | — | ||
| Q1 26 | $37.6B | — | ||
| Q4 25 | $36.3B | $29.7B | ||
| Q3 25 | $34.2B | $29.4B | ||
| Q2 25 | $33.6B | $28.7B | ||
| Q1 25 | $33.3B | $29.2B | ||
| Q4 24 | $34.4B | $28.9B | ||
| Q3 24 | $33.6B | $29.4B |
负债/权益比AMATTHC
| Q2 26 | 0.27× | — | ||
| Q1 26 | 0.30× | — | ||
| Q4 25 | — | 3.10× | ||
| Q3 25 | — | 3.26× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | — | 3.13× | ||
| Q4 24 | — | 3.14× | ||
| Q3 24 | — | 3.33× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $731.0M |
| 自由现金流经营现金流 - 资本支出 | — | $367.0M |
| 自由现金流率自由现金流/营收 | — | 6.6% |
| 资本支出强度资本支出/营收 | 8.0% | 6.6% |
| 现金转化率经营现金流/净利润 | — | 1.14× |
| 过去12个月自由现金流最近4个季度 | — | $2.5B |
8季度趋势，按日历期对齐
经营现金流AMATTHC
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $2.8B | $731.0M | ||
| Q3 25 | $2.6B | $1.1B | ||
| Q2 25 | $1.6B | $936.0M | ||
| Q1 25 | $925.0M | $815.0M | ||
| Q4 24 | $2.6B | $-331.0M | ||
| Q3 24 | $2.4B | $1.0B |
自由现金流AMATTHC
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $2.0B | $367.0M | ||
| Q3 25 | $2.0B | $778.0M | ||
| Q2 25 | $1.1B | $743.0M | ||
| Q1 25 | $544.0M | $642.0M | ||
| Q4 24 | $2.2B | $-661.0M | ||
| Q3 24 | $2.1B | $829.0M |
自由现金流率AMATTHC
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 30.0% | 6.6% | ||
| Q3 25 | 28.1% | 14.7% | ||
| Q2 25 | 14.9% | 14.1% | ||
| Q1 25 | 7.6% | 12.3% | ||
| Q4 24 | 30.8% | -13.0% | ||
| Q3 24 | 30.8% | 16.2% |
资本支出强度AMATTHC
| Q2 26 | 8.0% | — | ||
| Q1 26 | 9.2% | — | ||
| Q4 25 | 11.5% | 6.6% | ||
| Q3 25 | 8.0% | 5.3% | ||
| Q2 25 | 7.2% | 3.7% | ||
| Q1 25 | 5.3% | 3.3% | ||
| Q4 24 | 5.8% | 6.5% | ||
| Q3 24 | 4.4% | 4.2% |
现金转化率AMATTHC
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 1.49× | 1.14× | ||
| Q3 25 | 1.48× | 1.83× | ||
| Q2 25 | 0.74× | 1.79× | ||
| Q1 25 | 0.78× | 1.31× | ||
| Q4 24 | 1.49× | -0.58× | ||
| Q3 24 | 1.40× | 1.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMAT
暂无分部数据
THC
| Other | $2.9B | 52% |
| Health Care Patient Service | $1.4B | 25% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $1.2B | 22% |
| Health Care Other Sources | $56.0M | 1% |
